BIO - International Biopharmaceutical Industry

Current Edition

Issue 9, Volume 3

Current Features

Issue 9, Volume 3

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

news

Upstream Bio, a richly funded startup, reveals its lead drug and research plans

An inflammatory disease drug cast aside by Astellas Pharma has a new owner in Upstream Bio, an emerging biotechnology startup led by industry veteran Samantha Truex a...

6 June 2022 news BIO | Drug

Continue Reading →

news

Solid Bio joins slate of biotech layoffs, shedding 35% of its workforce

Dive Brief: Gene therapy developer Solid Biosciences is laying off 35% of its employees, announcing Wednesday a plan to extend its current funds for another two ye...

28 April 2022 news BIO | Biotech

Continue Reading →

news

BIO18: Pfizer (sort of) inches back to neuro; Building ties with FDA

BIO hits its goal Three days into the BIO International convention, the industry group touted breaking the G...

8 June 2018 news BIO | BIO18

Continue Reading →